This article introduces the concept of "weekend therapy", which has now become 
reality in diabetes. It briefly describes injectable and oral drugs which are 
currently available, or are in advanced stages of development, for use in once 
weekly administration. These include dulaglutide, exenatide QW, semaglutide, 
omarigliptin and trelagliptin.